KR980002259A - Method for producing species-specific protein antigen of Helicobacter pylori from recombinant E. coli - Google Patents

Method for producing species-specific protein antigen of Helicobacter pylori from recombinant E. coli Download PDF

Info

Publication number
KR980002259A
KR980002259A KR1019960020906A KR19960020906A KR980002259A KR 980002259 A KR980002259 A KR 980002259A KR 1019960020906 A KR1019960020906 A KR 1019960020906A KR 19960020906 A KR19960020906 A KR 19960020906A KR 980002259 A KR980002259 A KR 980002259A
Authority
KR
South Korea
Prior art keywords
ssa
fusion protein
coli
protein
histidine
Prior art date
Application number
KR1019960020906A
Other languages
Korean (ko)
Other versions
KR0177304B1 (en
Inventor
장호진
김천형
황상연
유영준
Original Assignee
성재갑
주식회사 Lg 화학
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 성재갑, 주식회사 Lg 화학 filed Critical 성재갑
Priority to KR1019960020906A priority Critical patent/KR0177304B1/en
Publication of KR980002259A publication Critical patent/KR980002259A/en
Application granted granted Critical
Publication of KR0177304B1 publication Critical patent/KR0177304B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/22Affinity chromatography or related techniques based upon selective absorption processes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/20Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/95Fusion polypeptide containing a motif/fusion for degradation (ubiquitin fusions, PEST sequence)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

본 발명은 대장균을 이용하여 헬리코박터 필로리(Helicobacter pylori : H. pylori)의 항원 결정부위 단백질인 종특이 단백질 항원(Species-Specific Protein Antigen : SSA)을 융합단백질의 형태로 제조하는 방법에 관한 것으로, 헬리코박터 필로리의 SSA 유전자에 히스티딘과 유비퀴틴 유전자가 연결된 융합유전자를 포함하는 His-Ub-SSA 융합단백질 발현벡터로 형질전환된 대장균을 융합단백질의 발현에 적합한 조건에서 배양하고, 융합단백질이 발현된 재조합 대장균 세포를 구아니딘 염이 포함된 완충용액에서 분쇄하고, 원심분리한 상등액을 히스티딘 결합수지 친화성 크로마토그래피하는 단계를 포함하는 본 발명의 His-Ub-SSA 융합단백질의 제조방법에 의하면 H. pylori 감염 진단과 백신 개발에 유용하게 사용될 수 있는 His-Ub-SSA 융합단백질을 높은 수율로 대량 생산할 수 있다.The present invention relates to a method for preparing a species-specific protein antigen (SSA), an antigenic determinant protein of Helicobacter pylori (H. pylori) using E. coli, in the form of a fusion protein. E. coli transformed with a His-Ub-SSA fusion protein expression vector comprising a fusion gene linked to histidine and ubiquitin genes to the SSA gene of Helicobacter pylori was cultured under conditions suitable for expression of the fusion protein, and the recombinant protein expressed with the fusion protein was expressed. According to the method for preparing the His-Ub-SSA fusion protein of the present invention, the method comprises the steps of pulverizing Escherichia coli cells in a buffer containing guanidine salt and subjecting the supernatant centrifuged to histidine-binding resin affinity chromatography. High-yield production of His-Ub-SSA fusion protein, which can be useful for diagnosis and vaccine development. All.

Description

재조합 대장균으로부터 헬리코박터 필로리의 종특이 단백질 항원 제조방법Method for producing species-specific protein antigen of Helicobacter pylori from recombinant E. coli

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

제1도는 종특이 단백질 항원(SSA) 유전자를 본 발명의 대장균 발현벡터 pETHUB-SSA로 클로닝하는 과정을 도시한 것이다.Figure 1 shows the procedure for cloning a species-specific protein antigen (SSA) gene into the E. coli expression vector pETHUB-SSA of the present invention.

제2도는 본 발명의 발현벡터 pETHUB-SSA로 형질전환된 대장균을 배양하여 얻은 세포 침전물을 변성 폴리아크릴아미드 겔 전기영동한 후 유비퀴틴 단일 항체를 이용하여 웨스턴 블롯팅(western blotting)한 결과를 나타낸 것이다.Figure 2 shows the result of Western blotting using a ubiquitin single antibody after denatured polyacrylamide gel electrophoresis of the cell precipitate obtained by culturing E. coli transformed with the expression vector pETHUB-SSA of the present invention .

제3도는 본 발명의 발현벡터 pETHUB-SSA로 형질전환된 대장균을 배양하여 얻은 세포 침전물을 변성 폴리아크릴아미드 겔 전기영동한 결과로서, IPTG로 발현 유도하기 전후를 비교한 것이다.3 is a result of denaturing polyacrylamide gel electrophoresis of cell precipitates obtained by culturing E. coli transformed with the expression vector pETHUB-SSA of the present invention.

Claims (6)

헬리코박터 필로리(Helicobacter pylori:H. pyori)의 종특이 단백질 항원(Species-Specific Protein Antigen:SSA) 유전자에 히스티딘과 유비퀴틴 유전자가 연결된 융합유전자.A fusion gene in which histidine and ubiquitin genes are linked to the Species-Specific Protein Antigen (SSA) gene of Helicobacter pylori (H. pyori). 제1항의 융합유전자를 포함하는 히스티딘-유비퀴틴-종특이 단백질 항원 (His-Ub-SSA) 융합단백질 발현벡터.A histidine-ubiquitin-species-specific protein antigen (His-Ub-SSA) fusion protein expression vector comprising the fusion gene of claim 1. 제2항에 있어서, 발현벡터 pETHUB-SSA.The expression vector pETHUB-SSA of claim 2. 제2항의 발현벡터로 형질전환된 대장균.E. coli transformed with the expression vector of claim 2. 제4항에 있어서, 대장균 BL21(DE3) pLYS.S(pET HUB SSA).The E. coli BL21 (DE3) pLYS.S (pET HUB SSA) according to claim 4. 제4항의 대장균을 융합단백질의 발현에 적합한 조건에서 배양하고, 융합단백질이 발현된 재조합 대장균 세포를 구아니딘 염이 포함된 완충용액에서 분쇄하고, 원심분리한 상등액을 히스티딘 결합수지 친화성 크로마토그래피하는 단계를 포함하는 His-Ub-SSA 융합단백질의 제조방법.E. coli is cultured under conditions suitable for the expression of the fusion protein, the recombinant E. coli cells expressing the fusion protein is pulverized in a buffer solution containing guanidine salt, and the centrifuged supernatant is subjected to histidine binding resin affinity chromatography Method for producing a His-Ub-SSA fusion protein comprising a. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019960020906A 1996-06-12 1996-06-12 Method for producing species specific protein antigen of Helicobacter pylori from recombinant E. coli KR0177304B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019960020906A KR0177304B1 (en) 1996-06-12 1996-06-12 Method for producing species specific protein antigen of Helicobacter pylori from recombinant E. coli

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019960020906A KR0177304B1 (en) 1996-06-12 1996-06-12 Method for producing species specific protein antigen of Helicobacter pylori from recombinant E. coli

Publications (2)

Publication Number Publication Date
KR980002259A true KR980002259A (en) 1998-03-30
KR0177304B1 KR0177304B1 (en) 1999-04-01

Family

ID=19461516

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019960020906A KR0177304B1 (en) 1996-06-12 1996-06-12 Method for producing species specific protein antigen of Helicobacter pylori from recombinant E. coli

Country Status (1)

Country Link
KR (1) KR0177304B1 (en)

Also Published As

Publication number Publication date
KR0177304B1 (en) 1999-04-01

Similar Documents

Publication Publication Date Title
ES2070172T3 (en) PROCEDURE FOR PRODUCING PROTEINS BY RECOMBINANT DNA.
Bechtel Identification of a high molecular weight actin-binding protein in skeletal muscle.
KR880011342A (en) DNA fragments encoding non-A non-B hepatitis specific antigens, expression vectors containing the DNA fragments, transformants, and methods of preparing the antigens
DE3587524D1 (en) PRODUCTION OF CHIMERIC ANTIBODY.
DK0613944T3 (en) Methods for regulating the immune response using CTLA4-binding molecules and IL4-binding molecules
KR840008693A (en) Preparation of immunoglobulins by recombinant techniques and methods of combining immunoglobulin amino acid sequences
CN103728447B (en) The antibody labeling method of controllable quantum dots locus specificity bridge joint coupling and application thereof
Meyer et al. Hormonal control of mitotic development in tobacco protoplasts: two-dimensional distribution of newly-synthesized proteins
WO1999013907A3 (en) Methods to improve immunogenicity of antigens and specificity of antibodies
KR980002259A (en) Method for producing species-specific protein antigen of Helicobacter pylori from recombinant E. coli
KR980002258A (en) Method for preparing urease B of Helicobacter pylori from recombinant E. coli
KR870010192A (en) Method for preparing fusion proteins and antibodies
KR980002257A (en) Method for preparing urease A of Helicobacter pylori from recombinant E. coli
Cheney et al. Intracellular movement of fodrin
ES2075068T3 (en) PROCEDURE FOR THE PREPARATION OF A PROTEIN BY MEANS OF YEAST USING AN INDUCIBLE SYSTEM, VECTORS AND CORRESPONDING TRANSFORMED STRAINS.
KR950018454A (en) How to produce protein C
Carden et al. Chemical cross-linking analyses of ox neurofilaments
Goodson et al. Amino acid sequence of Japanese quail (Coturnix japonica) and northern bobwhite (Colinus virginianus) myoglobin
Yang et al. Combinational biosynthesis of a fluorescent cyanobacterial holo-α-allophycocyanin in Escherichia coli
SE8800378L (en) PREPARATION OF FUSED PROTEINS OR POLYPEPTIDES
Muraoka et al. Three polypeptides with distinct biochemical properties are major α chain-size components of type IV collagen in bovine lens capsule
KR860008282A (en) Method for producing recombinant human lenin
KR970059276A (en) Method for producing the vacuolar cytotoxin protein of Helicobacter pylori from recombinant E. coli
TSUKITA et al. A high molecular weight protein in axoplasm underlying excitable membrane of squid giant axon
KR940021732A (en) Expression of the Nonstructural 4-Part Protein of Hepatitis C Virus

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20060915

Year of fee payment: 9

LAPS Lapse due to unpaid annual fee